When the COVID-19 pandemic broke out in 2020, the virus spread like wildfire, furious and by no means a respecter of persons. Major European cities imposed the strictest lockdowns in living memory, beginning in Italy then spreading across the continent. Collective panic descended on the world and businesses were shuttered. Many cities around the world…
Despite improvements in our understanding of the pathophysiology of pulmonary arterial hypertension (PAH), it remains a disease of significant morbidity and mortality. PAH is characterized by dyspnea/fatigue, a common presentation among patients with heart failure. A diagnosis of PAH can only be made when other cardiac/pulmonary causes of increased pulmonary arterial pressure have been ruled…
It would be interesting if PAH pathology can be assessed objectively through a wide lens in the hopes that its pathomechanisms become clear.
Recent research has uncovered unexpected links between gut microbiota and pulmonary arterial hypertension.
Researchers propose a new model for risk stratification in pulmonary arterial hypertension encompassing four risk categories.
Pregnant women with pulmonary arterial hypertension experience certain risks that require close monitoring.
Many diseases, including pulmonary arterial hypertension, cut across various medical specialties and require multidisciplinary cooperation.
Pulmonary arterial hypertension, once considered a disease of the young, is increasingly affecting patients of older age.
Although our understanding of PAH has significantly improved, we are still far away from a definitive cure.
Researchers are increasingly exploring the potential of gene therapy in treating respiratory diseases.
Please login or register first to view this content.
